IMRX - Immuneering Corp - Ordinary Shares Class A
IEX Last Trade
1.11
-0.050 -4.505%
Share volume: 264,507
Last Updated: Fri 30 Aug 2024 09:59:50 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$1.16
-0.05
-4.31%
Summary score
12%
Profitability
0%
Dept financing
2%
Liquidity
75%
Performance
10%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Sep-2019 - 30-Sep-2023
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-10.97%
Return on assets
-10.66%
Return on sales
-781840.19%
Return on invested capital
-170.62%
Total debt ratio
8.03%
Debt ratio change over timeo
-1.05%
Current Ratio
22.47%
Quick Ratio
22.47%
Cash Position Ratio
22.03%
Short-term ratios 30-Sep-2022 - 30-Sep-2023
The data are presented for the financials results of the quarters of the last year.
Return on equity
-12.17%
Return on assets
-12.03%
Return on sales
-3073627.91%
Return on invested capital
-181.89%
Total debt ratio
8.98%
Debt ratio change over timeo
-1.06%
Current Ratio
17.2%
Quick Ratio
17.2%
Cash Position Ratio
16.71%
Last quarter ratios 30-Sep-2023
The data are presented for the financials results of the last quarter.
Return on equity
-12.11%
Return on assets
-12.23%
Return on sales
0%
Return on invested capital
-164.09%
Total debt ratio
8.66%
Debt ratio change over time
-1.05%
Current Ratio
17.89%
Quick Ratio
17.89%
Cash Position Ratio
17.3%
Performance ratios (change over 4 years) 30-Sep-2019 - 30-Sep-2023
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-93.31%
Return on assets
-93.48%
Return on sales
454761.49%
Return on invested capital
2.57%
Total debt ratio
-104.84%
Debt ratio change over time
-1.05%
Current Ratio
-15.04%
Quick Ratio
-15.04%
Cash Position Ratio
-14.76%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | IMRX | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -10.97% | 7.58% | 36.15% | 7.75% |
| Return on assets | -10.66% | 2.95% | 3.44% | 5.85% |
| Return on sales | -781840.19% | 30.63% | 35.3% | 41.32% |
| Return on invested capital | -170.62% | 3.7% | 6.05% | 20.44% |
| Profitability | 0% | 41% | 68% | 80% |
| Total debt ratio | 8.03% | 92.36% | 89.3% | 27.07% |
| Debt ratio change over time | -1.05% | 292.67% | 15.45% | 1.02% |
| Dept financing | 2% | 50% | 25% | 7% |
| Current Ratio | 17.2% | 0.94% | 2.55% | 5.29% |
| Quick Ratio | 17.2% | 0.82% | 2.23% | 4.52% |
| Cash Position Ratio | 16.71% | 0.3% | 1.72% | 2.75% |
| Liquididy | 75% | 3% | 5% | 11% |
| Short-term ratios | IMRX | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -12.17% | 11.57% | 35.05% | 4.21% |
| Return on assets | -12.03% | 2.86% | 2.7% | 3.6% |
| Return on sales | -3073627.91% | 27.99% | 31.88% | 33.53% |
| Return on invested capital | -181.89% | 2.16% | 6.93% | 9.79% |
| Profitability | 0% | 54% | 85% | 78% |
| Total debt ratio | 8.98% | 89.83% | 93.1% | 22.12% |
| Debt ratio change over time | -1.06% | 102.83% | 13.09% | 1.3% |
| Dept financing | 2% | 49% | 28% | 6% |
| Current Ratio | 17.2% | 0.94% | 2.55% | 5.29% |
| Quick Ratio | 17.2% | 0.82% | 2.23% | 4.52% |
| Cash Position Ratio | 16.71% | 0.3% | 1.72% | 2.75% |
| Liquididy | 75% | 3% | 10% | 18% |